State-based Medicaid programs have begun using All Patient Refined–Diagnosis-Related Groups (APR-DRGs) to determine hospital reimbursement rates. This study examined how well APR-DRGs reflect admission costs for childhood cancer chemotherapy to inform clinicians, hospitals and policymakers in the wake of policy changes. Journal of Oncology Practice: http://bit.ly/21afa3r (subscription required)
